Healthcare Integrated Biobanking - HIB Copyright: Karin Kaiser, MHH MHH- Healthcare Integrated Biobanking MHH-HIB The „MHH- Healthcare Integrated Biobanking“ (MHH-HIB) is a new project of the Hannover

Thomas Illig reaches 2nd place in the ranking of Germany's most cited "minds" in hormone and metabolism research 4.09.2019 Copyright: TMF, GBN Prof. Dr. Thomas Illig, Scientific Director of the Hannov

Reporting obligations Duty to report adverse drug reactions in accordance with Section 16 of the Transfusion Act All adverse events associated with the use of blood products are subject to a reporting

Biobanks - essential for biomedical research Film of the GBA biobanks Film: "Biobanks - essential for biomedical research" The film of the German Biobank Alliance (GBA): "Biobanks - essential for biom

Responsibilities If an adverse reaction occurs during the transfusion, it must be interrupted or discontinued immediately and the transfusing physician must be informed. The latter will decide on furt

Clarification of a transfusion reaction Required materials To request clarification of a transfusion reaction, the Transfusion Reaction Request Card is used and sent immediately to the Institute of Tr

Immediate measures If a transfusion-associated adverse reaction is suspected, the following immediate measures are initiated: Interruption or discontinuation of the transfusion Leave access in place S

Medical researchers can now search a large pool of biosamples for relevant samples - this is made possible from a central location by the "Sample Locator" of the German Biobank Node (GBN). This is an

Current publications Clinical Ethics Working Group Here you will find an overview of the most recent publications by members of the Clinical Ethics Working Group. March 2022: Erdmann A, Spoden C, Hirs